Chang Liu

ORCID: 0000-0002-0200-1627
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Phagocytosis and Immune Regulation
  • Extracellular vesicles in disease
  • Photodynamic Therapy Research Studies
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery

China Pharmaceutical University
2014-2023

Abstract Atherosclerosis is a progressive inflammatory disease characterised by excessive lipid accumulation and cell infiltration the basis of most cardiovascular diseases peripheral arterial diseases. Therefore, an effectively targeted delivery system urgently needed to deliver ferroptosis‐specific inhibitors site plaque microenvironment. Inspired fact that neutrophils can be recruited plaques under action adhesion molecules chemokines, authors developed neutrophil membrane hybrid liposome...

10.1049/nbt2.12137 article EN cc-by IET Nanobiotechnology 2023-05-15

In order to improve Doxorubicin (Dox) targeting in vivo and reduce toxicity, use the ligand 2-deoxy-aminoglucose (2DG) modify form a new anti-tumor drug. The products was charactered by <sup>1</sup>H-NMR, MS, research near-infrared imaging. Compared with Dox , product treating MCF-7 U87MG cells shows higher antitumor activity vitro MTT assay. conclusion, modified effectively enhance pharmacodynamics contrast Dox, it would be potential therapeutic drug for cancer.

10.1117/12.2068712 article EN Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE 2014-09-16
Coming Soon ...